関連する実験動画
Updated: Nov 19, 2025

08:29
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
10.3K
アヌプロイド症は,癌細胞をミトーシスチェックポイントの抑制に脆弱にする
Yael Cohen-Sharir1, James M McFarland2, Mai Abdusamad2
1Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Nature
|January 28, 2021
まとめ
アヌプロイドがん細胞は 独特の脆弱性を表しています スピンドル・アセンブリ・チェックポイント (SAC) をターゲットにすると,長期的な増殖欠陥が明らかになり,がん治療の潜在的な治療標的としてKIF18Aが特定されます.
科学分野:
- 癌の生物学
- 細胞および分子腫瘍学
- 遺伝学
背景:
- アヌプロイジーは,異常な染色体数で,がんでは一般的ですが,その治療的影響は完全に理解されていません.
- 選択的にアヌプロイド細胞を標的とするのが 癌治療の有望な戦略です
- アヌプロイドがん細胞の臨床的に重要な脆弱性を特定することは極めて重要です.
研究 の 目的:
- ヒトの癌細胞系における アヌプロイドのパターンをマップする
- 遺伝的および化学的スクリーンを用いてアヌプロイド症に関連した細胞の脆弱性を特定する.
- アヌプロイド症の治療の可能性を調査する.
主な方法:
- ~1,000人の癌細胞系にわたるアヌプロイドの風景の分析
- 遺伝的および化学的干渉スクリーンの評価
- スピンドル・アセンブリ・チェックポイント (SAC) 阻害剤に対する癌細胞の感受性の評価
- アヌプロイド細胞におけるKIF18Aの役割の調査
主要な成果:
- アヌプロイドがん細胞は,SACの遺伝的障害に対する感受性が高まっている.
- アヌプロイド細胞は,短期的なSAC阻害に対する感受性の遅延を示し,ミトスの欠陥とカリオタイプの不安定性をもたらします.
- KIF18Aの減少は選択的にアヌプロイド細胞を傷つけ,その過剰発現はSACの抑制感を回復させる.
- アヌプロイド症とSAC阻害の間の合成的致死相互作用が特定されました.
結論:
- アヌプロイドがん細胞は,SACを阻害すると,長期にわたる増殖欠陥を有する.
- KIF18Aは,SAC抑制に対するアヌプロイド細胞反応の重要な要因です.
- アヌプロイド症とSAC阻害の間の合成的致死性は,がん治療のための潜在的な治療方法を示しています.
さらに関連する動画
関連する概念動画
Nondisjunction
4.5K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.5K
Nondisjunction
80.3K
During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
80.3K
Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
DNA Damage can Stall the Cell Cycle
9.7K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
DNA Damage Can Stall the Cell Cycle
2.9K
2.9K

